FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adolf Bauernfeind

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Disorders

Co-author Network

Publications

TOP 3
Rumyana Markovska; Ylia Marteva-Proevsk; Ivan Mitov; Ines Schneider; Adolf Bauernfeind; Boyka Markova
First detection of the AmpC beta-lactamase ACC-1 in a Klebsiella pneumoniae isolate in Bulgaria.
Rumyana Markovska; Ines Schneider; Mariya Sredkova; Temenuga Stoeva; Adolf Bauernfeind; Kalina Bojkova; Raina Gergova; Dobrinka Ivanova; Emma Keuleyan; Boyka Markova; Ivan Mitov
High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals.
Ines Schneider; Anne Marie Queenan; Rumyana Markovska; Boyka Markova; Emma Keuleyan; Adolf Bauernfeind
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adolf Bauernfeind (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rumyana Markovska; Ylia Marteva-Proevsk; Ivan Mitov; Ines Schneider; Adolf Bauernfeind; Boyka Markova
First detection of the AmpC beta-lactamase ACC-1 in a Klebsiella pneumoniae isolate in Bulgaria.
Journal of chemotherapy (Florence, Italy) 2012;24(5):307-8.
2012: Rumyana Markovska; Ines Schneider; Mariya Sredkova; Temenuga Stoeva; Adolf Bauernfeind; Kalina Bojkova; Raina Gergova; Dobrinka Ivanova; Emma Keuleyan; Boyka Markova; Ivan Mitov
High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals.
Microbial drug resistance (Larchmont, N.Y.) 2012;18(4):390-5.
2009: Ines Schneider; Anne Marie Queenan; Rumyana Markovska; Boyka Markova; Emma Keuleyan; Adolf Bauernfeind
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
Antimicrobial agents and chemotherapy 2009;53(10):4518-21.
2008: Ines Schneider; Emma Keuleyan; Rudolf Rasshofer; Rumyana Markovska; Anne Marie Queenan; Adolf Bauernfeind
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
Antimicrobial agents and chemotherapy 2008;52(8):2977-9.
2008: Rumyana Markovska; Ines Schneider; Emma Keuleyan; Mariya Sredkova; Dobrinka Ivanova; Boyka Markova; Grozdanka Lazarova; Elisaveta Dragijeva; Encho Savov; Irina Haydouchka; Nasya Hadjieva; Lena Setchanova; Ivan Mitov; Adolf Bauernfeind
Extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bulgarian hospitals.
Microbial drug resistance (Larchmont, N.Y.) 2008;14(2):119-28.
2008: Philipp Latzin; Maya Fehling; Adolf Bauernfeind; Dietrich Reinhardt; Matthias Kappler; Matthias Griese
Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2008;7(2):142-6.
2008: Zerrin Aktaş; Ciğdem Bal Kayacan; Ines Schneider; Bariş Can; Kenan Midilli; Adolf Bauernfeind
Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey.
Chemotherapy 2008;54(2):101-6.
2007: Ines Schneider; Rumyana Markovska; Emma Keuleyan; Mariya Sredkova; Katia Rachkova; Ivan Mitov; Adolf Bauernfeind
Dissemination and persistence of a plasmid-mediated TEM-3-like beta-lactamase, TEM-139, among Enterobacteriaceae in Bulgaria.
International journal of antimicrobial agents 2007;29(6):710-4.
2007: Ivelina Damjanova; Akos Tóth; Judit Pászti; Melinda Jakab; Hedda Milch; Adolf Bauernfeind; Miklós Füzi
Epidemiology of SHV-type beta-lactamase-producing Klebsiella spp. from outbreaks in five geographically distant Hungarian neonatal intensive care units: widespread dissemination of epidemic R-plasmids.
International journal of antimicrobial agents 2007;29(6):665-71.
2006: Ines Schneider; Anne Marie Queenan; Adolf Bauernfeind
Novel carbapenem-hydrolyzing oxacillinase OXA-62 from Pandoraea pnomenusa.
Antimicrobial agents and chemotherapy 2006;50(4):1330-5.
2006: I Damjanova; Akos Tóth; Judit Pászti; Adolf Bauernfeind; Miklós Füzi
Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(4):275-8.
2006: Rumyana Markovska; Emma Keuleyan; Ines Schneider; Boyka Markova; Katia Rachkova; M Sredkova; Adolf Bauernfeind
CTX-M-3 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and dissemination of the plasmidic blaCTX-M-3 in Bulgaria.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(2):123-5.
2005: Zerrin Aktaş; Nevriye Gönüllü; Ines Schneider; Cigdem Bal; Adolf Bauernfeind
[Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
Mikrobiyoloji bülteni 2005;39(4):421-9.
2005: Rumyana Markovska; Katia Rachkova; Ines Schneider; Emma Keuleyan; Adolf Bauernfeind
Multiresistant SHV-2-producing Salmonella enterica Serotype Corvallis in Bulgaria.
Journal of chemotherapy (Florence, Italy) 2005;17(5):568-9.
2005: F Otağ; G Ersöz; M Salcioğlu; Cigdem Bal; I Schneider; Adolf Bauernfeind
Nosocomial bloodstream infections with Burkholderia stabilis.
The Journal of hospital infection 2005;59(1):46-52.
2004: Rumyana Markovska; Ines Schneider; Emma Keuleyan; Adolf Bauernfeind
Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(8):752-5.
2003: Dongeun Yong; Jong Hee Shin; Sinyoung Kim; Youngsik Lim; Jong Hwa Yum; Kyungwon Lee; Yunsop Chong; Adolf Bauernfeind
High prevalence of PER-1 extended-spectrum beta-lactamase-producing Acinetobacter spp. in Korea.
Antimicrobial agents and chemotherapy 2003;47(5):1749-51.
2003: Philip Bufler; Bettina Schmidt; Daniela Schikor; Adolf Bauernfeind; Erika C Crouch; Matthias Griese
Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide.
American journal of respiratory cell and molecular biology 2003;28(2):249-56.
2002: A Jung; Irene Kleinau; Gabriele Schönian; Adolf Bauernfeind; C Chen; Matthias Griese; Gerd Döring; U Göbel; Ulrich Wahn; Karl Paul
Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients.
The European respiratory journal 2002;20(6):1457-63.
2002: F M E Wagenlehner; S Krcmery; C Held; Ingo Klare; Wolfgang Witte; Adolf Bauernfeind; I Schneider; K G Naber
Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters.
International journal of antimicrobial agents 2002;19(6):583-91.
1999: Adolf Bauernfeind; I Schneider; R Jungwirth; Hany Sahly; Uwe Ullmann
A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.
Antimicrobial agents and chemotherapy 1999;43(8):1924-31.
1999: Hany Sahly; V Boehme; Rainer Podschun; Adolf Bauernfeind; Ulrich R Fölsch; Uwe Ullmann
Infection and chronic colonization of an intensive care unit patient's respiratory tract by a Klebsiella pneumoniae strain producing a novel AmpC beta-lactamase different from that known.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(6):1338-9.
1999: Adolf Bauernfeind; I Schneider; R Jungwirth; Carsten Roller
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.
Journal of clinical microbiology 1999;37(5):1335-9.
1998: Adolf Bauernfeind; Y Chong; K Lee
Plasmid-encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery?
Yonsei medical journal 1998;39(6):520-5.
1998: M Fille; Adolf Bauernfeind; E Eberlein; R Jungwirth; I Schneider; G Speer; M P Dierich; F Allerberger
[Imipenem resistance in Pseudomonas aeruginosa].
Wiener klinische Wochenschrift 1998;110(20):715-20.
1998: Adolf Bauernfeind; I Schneider; R Jungwirth; Carsten Roller
Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.
Journal of clinical microbiology 1998;36(9):2748-51.
1998: Adolf Bauernfeind; Carsten Roller; D Meyer; R Jungwirth; I Schneider
Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei.
Journal of clinical microbiology 1998;36(9):2737-41.
1998: Marek Gniadkowski; I Schneider; A Pałucha; R Jungwirth; B Mikiewicz; Adolf Bauernfeind
Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme.
Antimicrobial agents and chemotherapy 1998;42(4):827-32.
1998: Marek Gniadkowski; I Schneider; R Jungwirth; Waleria Hryniewicz; Adolf Bauernfeind
Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.
Antimicrobial agents and chemotherapy 1998;42(3):514-20.
1998: HG Wiesemann; Gratiana Steinkamp; Felix Ratjen; Adolf Bauernfeind; B Przyklenk; Gerd Döring; Horst von der Hardt
Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
Pediatric pulmonology 1998;25(2):88-92.
1997: Adolf Bauernfeind
Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin.
The Journal of antimicrobial chemotherapy 1997;40(5):639-51.
1997: Adolf Bauernfeind; S Wagner; R Jungwirth; I Schneider; D Meyer
A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.
Antimicrobial agents and chemotherapy 1997;41(9):2041-6.
1997: Adolf Bauernfeind; B Przyklenk
Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
Behring Institute Mitteilungen 1997;(98):256-61.
1997: Marianne Abele-Horn; A Dauber; Adolf Bauernfeind; W Russwurm; I Seyfarth-Metzger; P Gleich; Gotthart Ruckdeschel
Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD).
Intensive care medicine 1997;23(2):187-95.
1996: Adolf Bauernfeind; I Stemplinger; R Jungwirth; R Wilhelm; Y Chong
Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes.
Antimicrobial agents and chemotherapy 1996;40(8):1926-30.
1996: Adolf Bauernfeind
Antibiotic susceptibility patterns of respiratory isolates of Klebsiella pneumoniae in Europe and the USA in 1992 and 1993. The Alexander Project Collaborative Group.
The Journal of antimicrobial chemotherapy 1996;38 Suppl A():107-15.
1996: Franz Allerberger; T Koeuth; C Lass-FLörl; M P Dierich; C Putensen; E Scmutzhard; I Mohsenipour; HJ Grundmann; Doris Hartung; Adolf Bauernfeind; E Eberlein; J R Lupski
Epidemiology of infections due to multiresistant Enterobacter aerogenes in a university hospital.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(6):517-21.
1996: Wolfgang M Prodinger; Manfred Fille; Adolf Bauernfeind; I Stemplinger; S Amann; Bettina Pfausler; C Lass-Florl; Manfred P Dierich
Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer.
Journal of clinical microbiology 1996;34(3):564-8.
1996: Adolf Bauernfeind; I Stemplinger; R Jungwirth; P Mangold; S Amann; E Akalin; O Anğ; C Bal; J M Casellas
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.
Antimicrobial agents and chemotherapy 1996;40(3):616-20.
1996: Adolf Bauernfeind; I Stemplinger; R Jungwirth; S Ernst; J M Casellas
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases.
Antimicrobial agents and chemotherapy 1996;40(2):509-13.
1996: Adolf Bauernfeind; I Stemplinger; R Jungwirth; Helen Giamarellou
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.
Antimicrobial agents and chemotherapy 1996;40(1):221-4.
1995: Adolf Bauernfeind; R Jungwirth; E Eberlein
Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.
Infection 1995;23(5):316-21.
1993: Adolf Bauernfeind
Questioning dosing regimens of ciprofloxacin.
The Journal of antimicrobial chemotherapy 1993;31(5):789-98.
1993: Adolf Bauernfeind
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
The Journal of antimicrobial chemotherapy 1993;31(4):505-22.
1993: Adolf Bauernfeind
In-vitro activity of dirithromycin in comparison with other new and established macrolides.
The Journal of antimicrobial chemotherapy 1993;31 Suppl C():39-49.
1993: Adolf Bauernfeind; E Rosenthal; E Eberlein; M Holley; S Schweighart
Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients.
Infection 1993;21(1):18-22.
1992: Adolf Bauernfeind
Bactericidal activity of antibiotics alone and in combination against Enterococcus faecalis in a pharmacodynamic model.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;15(3):481-5.
1992: Adolf Bauernfeind; J M Casellas; M Goldberg; M Holley; R Jungwirth; P Mangold; T Röhnisch; S Schweighart; R Wilhelm
A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.
Infection 1992;20(3):158-63.
1992: A Markus; N Klesel; T Wollmann; D Isert; M Limbert; E Schrinner; G Seibert; Adolf Bauernfeind; R Jungwirth; R Wilhelm
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
The Journal of antibiotics 1992;45(4):521-6.
1992: Adolf Bauernfeind; R Jungwirth; E Eberlein; N Klesel; F Adam; D Isert; M Limbert; A Markus; E Schrinner; G Seibert
RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.
The Journal of antibiotics 1992;45(4):505-20.
1991: Adolf Bauernfeind; R Jungwirth
Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Infection 1991;19(5):353-62.
1991: Adolf Bauernfeind; H Grimm; W Klietmann; W Opferkuch; H Werner
[The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime].
Arzneimittel-Forschung 1991;41(8):831-8.
1991: Adolf Bauernfeind
Ceftibuten and bactericidal kinetics. Comparative in vitro activity against Enterobacteriaceae producing extended spectrum beta-lactamases.
Diagnostic microbiology and infectious disease 1991;14(1):89-92.
1991: Adolf Bauernfeind
Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
Diagnostic microbiology and infectious disease 1991;14(1):63-74.
1991: Adolf Bauernfeind; S Schweighart; E Eberlein; R Jungwirth
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Infection 1991;19 Suppl 5():S264-75.
1990: Adolf Bauernfeind; H Grimm; S Schweighart
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.
Infection 1990;18(5):294-8.
1990: Adolf Bauernfeind; B Przyklenk; C Matthias; R Jungwirth; R M Bertele; K Harms
Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients.
Infection 1990;18(2):126-30.
1990: B Przyklenk; Adolf Bauernfeind; W Bornschein; G Emminger; K Heilmann; S Schweighart
The role of Campylobacter (Helicobacter) pylori in disorders of the gastrointestinal tract.
Infection 1990;18(1):3-7.
1990: Adolf Bauernfeind; R Jungwirth; S Schweighart; M Theopold
[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Infection 1990;18 Suppl 3():S155-67.
1990: R V Goering; Adolf Bauernfeind; W Lenz; B Przyklenk
Staphylococcus aureus in patients with cystic fibrosis: an epidemiological analysis using a combination of traditional and molecular methods.
Infection 1990;18(1):57-60.
1989: Adolf Bauernfeind; Y Chong; S Schweighart
Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.
Infection 1989;17(5):316-21.
1989: Adolf Bauernfeind; R Jungwirth; S Schweighart
In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
The Journal of antimicrobial chemotherapy 1989;24 Suppl A():73-84.
1989: W Bornschein; K L Heilmann; Adolf Bauernfeind
[Intragastric formation of ammonia in Campylobacter pylori associated gastritis. Diagnostic and pathogenetic significance].
Medizinische Klinik (Munich, Germany : 1983) 1989;84(7):329-32, 368.
1989: W Bornschein; Adolf Bauernfeind; K L Heilmann
[A rapid urease test in Campylobacter pylori colonization of the gastric mucosa].
Gastroenterologisches Journal : Organ der Gesellschaft für Gastroenterologie der DDR 1989;49(2):54-8.
1988: Adolf Bauernfeind; E Eberlein; G Hörl
Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures.
The Journal of antimicrobial chemotherapy 1988;22 Suppl D():81-9.
1988: W Bornschein; Adolf Bauernfeind; K Heilmann
[Campylobacter pylori colonization of duodenal and gastric mucosa in duodenitis and duodenal ulcer].
Medizinische Klinik (Munich, Germany : 1983) 1988;83(18):585-9.
1988: Adolf Bauernfeind; G Hörl; B Przyklenk
Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
Scandinavian journal of gastroenterology. Supplement 1988;143():99-102.
1988: B Przyklenk; Adolf Bauernfeind
Significance of immunologic factors in cystic fibrosis.
Scandinavian journal of gastroenterology. Supplement 1988;143():103-9.
1987: Adolf Bauernfeind; G Emminger; G Hörl; B Lorbeer; B Przyklenk; C Weisslein-Pfister
Selective pressure of antistaphylococcal chemotherapeutics in favour of Pseudomonas aeruginosa in cystic fibrosis.
Infection 1987;15(6):469-70.
1987: B Przyklenk; Adolf Bauernfeind; G Hörl; G Emminger
Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis.
Infection 1987;15(4):308-10.
1987: Adolf Bauernfeind; G Hörl
Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins.
Infection 1987;15(4):257-9.
1987: Adolf Bauernfeind; K Rotter; C Weisslein-Pfister
Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.
Infection 1987;15(4):278-80.
1987: Adolf Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
Infection 1987;15(4):270-7.
1987: Adolf Bauernfeind; G Hörl; B Przyklenk
Microbiological perspectives of co-trimoxazole.
Infection 1987;15 Suppl 5():S232-5.
1987: Adolf Bauernfeind; G Emminger; G Hörl; S Ott; B Przyklenk; C Weisslein-Pfister
Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
Infection 1987;15(5):403-6.
1986: Adolf Bauernfeind; G Hörl
[Imipenem resistance in Pseudomonas aeruginosa].
Immunität und Infektion 1986;14(6):221-4.
1986: Adolf Bauernfeind; C Petermüller; B Heinrich; R Gablac
[Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].
Infection 1986;14 Suppl 1():S26-30.
1985: Adolf Bauernfeind; B Przyklenk; C Petermüller
[Antibacterial antibodies in immunoglobulins].
Arzneimittel-Forschung 1985;35(4):780.
1984: Adolf Bauernfeind; C Petermüller
Typing of Enterobacter spp. by bacteriocin susceptibility and its use in epidemiological analysis.
Journal of clinical microbiology 1984;20(1):70-3.
1983: Adolf Bauernfeind; C Petermüller
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
European journal of clinical microbiology 1983;2(2):111-5.
1983: Adolf Bauernfeind; C Petermüller; R Jungwirth
Inactivation of cephalosporins by beta-lactamases of gram-negative rods.
Infection 1983;11 Suppl 1():S39-43.
1982: Adolf Bauernfeind; C Petermüller
In vitro activity of teichomycin A 2 in comparison with penicillin and vancomycin against gram-positive cocci.
European journal of clinical microbiology 1982;1(5):278-81.
1982: Adolf Bauernfeind; R Jungwirth; C Petermüller
Simultaneous simulation of the serum profiles of two antibiotics and analysis of the combined effect against a culture of Pseudomonas aeruginosa.
Chemotherapy 1982;28(5):334-40.
1981: Adolf Bauernfeind
An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1981;8 Suppl B():111-7.
1981: Adolf Bauernfeind; C Petermüller; R Schneider
Bacteriocins as tools in analysis of nosocomial Klebsiella pneumoniae infections.
Journal of clinical microbiology 1981;14(1):15-9.
1980: Adolf Bauernfeind; C Petermüller
Chemotherapy with cefotaxime: how to avoid selection of Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1980;6(5):671-2.